List of articles with "Multiple Myeloma"

DARZALEX® Approval

DARZALEX® Approval

None Halozyme Multiple Myeloma DARZALEX
Transforming Myeloma Care

Transforming Myeloma Care

None Multiple Myeloma DARZALEX Janssen
Myeloma Market Growth

Myeloma Market Growth

None CAR-T therapy Multiple Myeloma DARZALEX
SkylineDx Unveils SKY92 Test

SkylineDx Unveils SKY92 Test

Netherlands Multiple Myeloma Rotterdam SkylineDx SKY92
KPG-818 IND Approval

KPG-818 IND Approval

China Hefei Multiple Myeloma Kangpu Biopharmaceuticals KPG-818
XPOVIO® Approved in Taiwan

XPOVIO® Approved in Taiwan

Taiwan Taipei XPOVIO Multiple Myeloma Antengene
New Antibody for Myeloma

New Antibody for Myeloma

USA Multiple Myeloma AbbVie North Chicago Simcere Zaiming
Innovative Cancer Partnership

Innovative Cancer Partnership

United States Multiple Myeloma AbbVie North Chicago Simcere Zaiming
AbbVie and Simcere Team Up

AbbVie and Simcere Team Up

United States Multiple Myeloma AbbVie North Chicago Simcere Zaiming
Promising Data for Lisaftoclax

Promising Data for Lisaftoclax

USA San Diego Ascentage Pharma Multiple Myeloma Lisaftoclax
CAR T-Cell Study Insights

CAR T-Cell Study Insights

China Shanghai Multiple Myeloma IASO Bio CAR T-Cell
CARVYKTI® Breakthrough

CARVYKTI® Breakthrough

USA San Diego Johnson & Johnson Multiple Myeloma CARVYKTI
Advances with DARZALEX FASPRO®

Advances with DARZALEX FASPRO®

United States San Diego Johnson & Johnson Multiple Myeloma DARZALEX FASPRO
TECVAYLI® in Myeloma Treatment

TECVAYLI® in Myeloma Treatment

USA San Diego Johnson & Johnson Multiple Myeloma TECVAYLI®
DARZALEX FASPRO® Breakthrough

DARZALEX FASPRO® Breakthrough

United States San Diego Johnson & Johnson Multiple Myeloma DARZALEX FASPRO
Breakthrough in Myeloma Care

Breakthrough in Myeloma Care

Netherlands Multiple Myeloma Rotterdam SkylineDx SKY92
K36 Reveals KTX-1001 Data

K36 Reveals KTX-1001 Data

USA San Diego KTX-1001 K36 Therapeutics Multiple Myeloma

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.